1. Home
  2. TH vs URGN Comparison

TH vs URGN Comparison

Compare TH & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

HOLD

Current Price

$16.13

Market Cap

1.8B

ML Signal

HOLD

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$40.93

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TH
URGN
Founded
1978
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
TH
URGN
Price
$16.13
$40.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$16.50
$29.29
AVG Volume (30 Days)
1.1M
782.4K
Earning Date
05-18-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$320,635,000.00
$1,128,000.00
Revenue This Year
$17.45
$129.09
Revenue Next Year
$38.19
$70.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.97
$15.86
52 Week High
$20.85
$43.93

Technical Indicators

Market Signals
Indicator
TH
URGN
Relative Strength Index (RSI) 35.60 63.35
Support Level $15.95 $18.23
Resistance Level $16.12 N/A
Average True Range (ATR) 0.69 2.11
MACD -0.22 -0.05
Stochastic Oscillator 1.17 61.79

Price Performance

Historical Comparison
TH
URGN

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services, including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. The company has three reportable segments: HFS - South, which provides specialty rental and hospitality services to the natural resources and development industry; WHS, which provides construction and hospitality solutions for critical mineral and data center projects; and Government, which provides specialty rental and hospitality services under government contracts.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

Share on Social Networks: